SEC FORM 4CLUSTER · 5 INSIDERS
$825,000.00
Hepion Pharmaceuticals, Inc. (HEPA)
Purchase of 16,500,000 shares across 5 reporting persons.
Transaction Code P · Reporting Persons 5
- Appajosyula Sireesh, Chief Operating OfficerPurchase of 2,000,000 shares at $0.05 per share.$100,000.00
- LoPriore Vincent S, Executive ChairmanPurchase of 8,000,000 shares at $0.05 per share.$400,000.00
- LoPriore Vincent S, Executive ChairmanPurchase of 2,000,000 shares at $0.05 per share.$100,000.00
- Purcell Michael J.Purchase of 2,000,000 shares at $0.05 per share.$100,000.00
- Stetz Gary S., Interim CEOPurchase of 2,000,000 shares at $0.05 per share.$100,000.00
- Stetz Gary S. IIPurchase of 500,000 shares at $0.05 per share.$25,000.00
Surfaced by rule: 5 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.
Traded Aug 3, 2026 · Disclosed Aug 12, 2026FILED +9 DAYS
Source: SEC Form 4 · 0001493152-26-037490 · filed 2026-08-12 · View filing →
Source: SEC Form 4 · 0001493152-26-037489 · filed 2026-08-12 · View filing →
Source: SEC Form 4 · 0001493152-26-037493 · filed 2026-08-12 · View filing →
Source: SEC Form 4 · 0001493152-26-037496 · filed 2026-08-12 · View filing →
Source: SEC Form 4 · 0001493152-26-037500 · filed 2026-08-12 · View filing →